CHARLESTON — Opioid manufacturers’ compliance with the federal Controlled Substances Act depended heavily on the judgment, diligence and action of compliance executives and other employees at those companies, according to
CHARLESTON — Opioid manufacturers’ compliance with the federal Controlled Substances Act depended heavily on the judgment, diligence and action of compliance executives and other employees at those companies, according to
CHARLESTON — Dr. Matthew Christiansen, head of the West Virginia Office of Drug Control Policy, took the stand Friday in the state’s ongoing opioid trial to explain how the addiction
CHARLESTON — Attorneys for the state of West Virginia attempted to have opioid manufacturers clarify what was accepted practice and what was written policy in determining if the manufacturers properly
CHARLESTON — Attorneys for pharmaceutical companies spent most of Wednesday cross-examining an expert witness who previously testified on how West Virginia was an “outlier” and a leader, compared to the